TXG

NASDAQStock

10x Genomics, Inc.

$19.00-1.44 (-7.04%)

52-Week Range

$7.14
$23.19

Key Stats

Market Cap

2.4B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.21

Volume

1.6M

Avg Volume

2.3M

Performance

1M

-1.10%

3M

+20.18%

6M

+41.87%

YTD

+13.96%

1Y

+91.70%

3Y

-61.08%

5Y

-88.83%

Price Chart

ETF Exposure

TXG is held by 91 ETFs

ETFFund NameWeight
JKJiShares Morningstar Small-Cap ETF0.04%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.04%
VTWGVanguard Russell 2000 Growth ETF0.04%
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF0.03%
VHTVanguard Health Care ETF0.03%
TLTDFlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund0.03%
VBVanguard Small-Cap ETF0.03%
VXFVanguard Extended Market ETF0.03%
DXUVDimensional - US Vector Equity ETF0.03%
SMMDiShares Russell 2500 ETF0.02%
DFSUDimensional - US Sustainability Core 1 ETF0.01%
DCORDimensional - US Core Equity 1 ETF0.01%
HDGProShares - Hedge Replication ETF0.01%
TILTFlexShares Morningstar U.S. Market Factor Tilt Index Fund0.01%
MFDXPIMCO RAFI Dynamic Multi-Factor International Equity ETF0.01%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.01%
DFACDimensional - US Core Equity 2 ETF0.01%
DFAUDimensional - US Core Equity Market ETF0.01%
ESGVVanguard ESG U.S. Stock ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
DFUSDimensional - US Equity Market ETF0.00%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
AVUSAvantis U.S. Equity ETF0.00%
GTPEGoldman Sachs MSCI World Private Equity Return Tracker ETF0.00%
VTVanguard Total World Stock ETF0.00%
AVSUAvantis Responsible U.S. Equity ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
V3AL.LVanguard ESG Global All Cap UCITS ETF (USD) Distributing0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
PreviousPage 2 of 2

About TXG ETF Exposure

10x Genomics, Inc. (TXG) is held by 91 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.4B, TXG is a widely held institutional stock. The stock currently trades at $19.00. Investors can gain exposure to TXG through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TXG, sorted by portfolio weight.